Literature DB >> 16333129

Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections.

Elisa Martró1, Barbara Suligoi, Victoria González, Vincenzo Bossi, Anna Esteve, Joanne Mei, Vicenç Ausina.   

Abstract

A study was designed to compare an avidity index method to the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion (STARHS) for the detection of recent HIV infection. One hundred sixty HIV-positive sera were tested. Both techniques performed similarly in identifying recent infections, although STARHS tended to misclassify more individuals that had long-standing infection as being recently infected.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16333129      PMCID： PMC1317229          DOI： 10.1128/JCM.43.12.6197-6199.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy.

Authors:  M Eggers; U Bäder; G Enders
Journal:  J Med Virol       Date:  2000-03       Impact factor: 2.327

2.  Test of HIV incidence shows continuing HIV transmission in homosexual/bisexual men in England and Wales.

Authors:  G Murphy; J V Parry; S B Gupta; C Graham; L F Jordan; A N Nicoll; O N Gill
Journal:  Commun Dis Public Health       Date:  2001-03

3.  Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors.

Authors:  Daisy M Machado; Eric L Delwart; Ricardo S Diaz; Carlos F de Oliveira; Katia Alves; Bhupat D Rawal; Marian Sullivan; Marta Gwinn; Kenneth A Clark; Michael P Busch
Journal:  AIDS       Date:  2002-01-04       Impact factor: 4.177

4.  High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion.

Authors:  Eleanor Gouws; Brian G Williams; Haynes W Sheppard; Barryett Enge; Salim Abdool Karim
Journal:  J Acquir Immune Defic Syndr       Date:  2002-04-15       Impact factor: 3.731

Review 5.  Surveillance for incident HIV infection: new technology and new opportunities.

Authors:  G W Rutherford; S K Schwarcz; W McFarland
Journal:  J Acquir Immune Defic Syndr       Date:  2000-12-15       Impact factor: 3.731

6.  Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San Francisco.

Authors:  W McFarland; M P Busch; T A Kellogg; B D Rawal; G A Satten; M H Katz; J Dilley; R S Janssen
Journal:  J Acquir Immune Defic Syndr       Date:  1999-12-15       Impact factor: 3.731

7.  Differences in the temporal trends of HIV seroincidence and seroprevalence among sexually transmitted disease clinic patients, 1989-1998: application of the serologic testing algorithm for recent HIV seroconversion.

Authors:  S Schwarcz; T Kellogg; W McFarland; B Louie; R Kohn; M Busch; M Katz; G Bolan; J Klausner; H Weinstock
Journal:  Am J Epidemiol       Date:  2001-05-15       Impact factor: 4.897

8.  Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations.

Authors:  L Matter; K Kogelschatz; D Germann
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

9.  HIV incidence appears constant in men who have sex with men despite widespread use of effective antiretroviral therapy.

Authors:  Gary Murphy; Andre Charlett; Laura F Jordan; Natasha Osner; O Noel Gill; John V Parry
Journal:  AIDS       Date:  2004-01-23       Impact factor: 4.177

10.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

Authors:  R S Janssen; G A Satten; S L Stramer; B D Rawal; T R O'Brien; B J Weiblen; F M Hecht; N Jack; F R Cleghorn; J O Kahn; M A Chesney; M P Busch
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272
View more
  15 in total

1.  Changes in function of HIV-specific T-cell responses with increasing time from infection.

Authors:  Michel L Ndongala; Philomena Kamya; Salix Boulet; Yoav Peretz; Danielle Rouleau; Cécile Tremblay; Roger Leblanc; Pierre Côté; Jean-Guy Baril; RéJean Thomas; Sylvie Vézina; Mohamed R Boulassel; Jean-Pierre Routy; Rafick P Sékaly; Nicole F Bernard
Journal:  Viral Immunol       Date:  2010-04       Impact factor: 2.257

2.  A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses.

Authors:  Salix Boulet; Michel L Ndongala; Yoav Peretz; Marie-Pierre Boisvert; Mohamed-Rachid Boulassel; Cecile Tremblay; Jean-Pierre Routy; Rafick-P Sekaly; Nicole F Bernard
Journal:  J Immunol Methods       Date:  2006-12-29       Impact factor: 2.303

3.  MSM in Bogotá are living with HIV for extended periods without diagnosis or treatment.

Authors:  Maria Cecilia Zea; Patricia Olaya; Carol A Reisen; Paul J Poppen
Journal:  Int J STD AIDS       Date:  2016-11-21       Impact factor: 1.359

4.  Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward.

Authors:  Timothy D Mastro; Andrea A Kim; Timothy Hallett; Thomas Rehle; Alex Welte; Oliver Laeyendecker; Tom Oluoch; Jesus M Garcia-Calleja
Journal:  J HIV AIDS Surveill Epidemiol       Date:  2010-01-01

5.  Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes.

Authors:  A Chawla; G Murphy; C Donnelly; C L Booth; M Johnson; J V Parry; A Phillips; A M Geretti
Journal:  J Clin Microbiol       Date:  2006-12-06       Impact factor: 5.948

6.  Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation.

Authors:  Sheila M Keating; Debra Hanson; Mila Lebedeva; Oliver Laeyendecker; N'ko L Ali-Napo; S Michele Owen; Susan L Stramer; Richard D Moore; Philip J Norris; Michael P Busch
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

7.  Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay.

Authors:  Oliver Laeyendecker; Jessica D Church; Amy E Oliver; Anthony Mwatha; S Michele Owen; Deborah Donnell; Ron Brookmeyer; Philippa Musoke; J Brooks Jackson; Laura Guay; Clemesia Nakabiito; Thomas C Quinn; Susan H Eshleman
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

8.  Comparison of the human immunodeficiency virus (HIV) type 1-specific immunoglobulin G capture enzyme-linked immunosorbent assay and the avidity index method for identification of recent HIV infections.

Authors:  Stephan Loschen; Jörg Bätzing-Feigenbaum; Gabriele Poggensee; Christiane Cordes; Bettina Hintsche; Michael Rausch; Stephan Dupke; Silvia Gohlke-Micknis; Jana Rödig; Osamah Hamouda; Claudia Kücherer
Journal:  J Clin Microbiol       Date:  2007-10-31       Impact factor: 5.948

9.  The effect of viral suppression on cross-sectional incidence testing in the johns hopkins hospital emergency department.

Authors:  Oliver Laeyendecker; Richard E Rothman; Charlamaine Henson; Bobbi Jo Horne; Kerunne S Ketlogetswe; Chadd K Kraus; Judy Shahan; Gabor D Kelen; Thomas C Quinn
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

10.  Evolution of Antibodies to Native Trimeric Envelope and Their Fc-Dependent Functions in Untreated and Treated Primary HIV Infection.

Authors:  Franck P Dupuy; Nicole F Bernard; Lauren Nagel; Sanket Kant; Christopher Leeks; Jean-Pierre Routy; Cécile Tremblay; Réjean Thomas; Jason Szabo; Pierre Côté; Benoit Trottier; Roger LeBlanc; Danielle Rouleau
Journal:  J Virol       Date:  2021-09-29       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.